129 related articles for article (PubMed ID: 20638758)
1. [Acquired factor V deficiency: a rare bleeding disorder with variable clinical presentations].
Alcantara M; Ducastelle S; Rugeri L; Dargaud Y
Rev Med Interne; 2011 May; 32(5):e59-61. PubMed ID: 20638758
[TBL] [Abstract][Full Text] [Related]
2. Acquired factor V inhibitor after exposure to topical human thrombin related to an otorhinolaryngological procedure.
Donohoe K; Levine R
J Thromb Haemost; 2015 Oct; 13(10):1787-9. PubMed ID: 26270511
[TBL] [Abstract][Full Text] [Related]
3. Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding.
Ajzner E; Balogh I; Haramura G; Boda Z; Kalmár K; Pfliegler G; Dahlbäck B; Muszbek L
J Thromb Haemost; 2003 May; 1(5):943-9. PubMed ID: 12871359
[TBL] [Abstract][Full Text] [Related]
4. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors.
de Raucourt E; Barbier C; Sinda P; Dib M; Peltier JY; Ternisien C
Am J Hematol; 2003 Nov; 74(3):187-90. PubMed ID: 14587047
[TBL] [Abstract][Full Text] [Related]
5. Modulation of an acquired coagulation factor V inhibitor with intravenous immune globulin.
Tarantino MD; Ross MP; Daniels TM; Nichols WL
J Pediatr Hematol Oncol; 1997; 19(3):226-31. PubMed ID: 9201145
[TBL] [Abstract][Full Text] [Related]
6. Clinical and laboratory diagnosis of autoimmune factor V inhibitors: A single institutional experience.
Sridharan M; Fylling KA; Ashrani AA; Chen D; Marshall AL; Hook CC; Cardel LK; Nichols WL; Pruthi RK
Thromb Res; 2018 Nov; 171():14-21. PubMed ID: 30227314
[TBL] [Abstract][Full Text] [Related]
7. Multimodality therapy of an acquired factor V inhibitor.
Fu YX; Kaufman R; Rudolph AE; Collum SE; Blinder MA
Am J Hematol; 1996 Apr; 51(4):315-8. PubMed ID: 8602633
[TBL] [Abstract][Full Text] [Related]
8. Transfusion management of factor V deficiency: three case reports and review of the literature.
Gavva C; Yates SG; Rambally S; Sarode R
Transfusion; 2016 Jul; 56(7):1745-9. PubMed ID: 27125565
[TBL] [Abstract][Full Text] [Related]
9. Acquired factor V deficiency in a patient with a urinary tract infection presenting with haematuria followed by multiple haemorrhages with an extremely low level of factor V inhibitor: a case report and review of the literature.
Wang X; Qin X; Yu Y; Wang R; Liu X; Ji M; Zhou M; Chen C
Blood Coagul Fibrinolysis; 2017 Jun; 28(4):334-341. PubMed ID: 27428013
[TBL] [Abstract][Full Text] [Related]
10. Acquired factor V inhibitor complicated by Hashimoto's thyroditis, primary biliary cirrhosis and membranous nephropathy.
Takahashi H; Fuse I; Abe T; Yoshino N; Aizawa Y
Blood Coagul Fibrinolysis; 2003 Jan; 14(1):87-93. PubMed ID: 12544735
[TBL] [Abstract][Full Text] [Related]
11. Development of cephradine-induced acquired factor V inhibitors: a case report.
Wu MT; Pei SN
Ann Pharmacother; 2010 Oct; 44(10):1673-6. PubMed ID: 20807866
[TBL] [Abstract][Full Text] [Related]
12. Factor V inhibitors: rare or not so uncommon? A multi-laboratory investigation.
Favaloro EJ; Posen J; Ramakrishna R; Soltani S; McRae S; Just S; Aboud M; Low J; Gemmell R; Kershaw G; Coleman R; Dean M
Blood Coagul Fibrinolysis; 2004 Oct; 15(8):637-47. PubMed ID: 15613918
[TBL] [Abstract][Full Text] [Related]
13. Postoperative bleeding in an elderly patient from acquired factor V inhibitor: rapid response to immunosuppressive therapy.
Bobba RK; Garg P; Arya M; Freter CE
Am J Med Sci; 2011 Mar; 341(3):253-6. PubMed ID: 21289509
[TBL] [Abstract][Full Text] [Related]
14. The potential value of thrombin generation assay in the diagnosis of FV inhibitors.
Désage S; Jousselme E; Le Quellec S; Lienhart A; Nougier C; Dargaud Y; Jourdy Y
Int J Lab Hematol; 2019 Oct; 41(5):e117-e120. PubMed ID: 30953579
[No Abstract] [Full Text] [Related]
15. Management of bleeding in severe factor V deficiency with a factor V inhibitor.
Ardillon L; Lefrançois A; Graveleau J; Fouassier M; Ternisien C; Sigaud M; Fretigny M; Archambeaud I; Trossaërt M
Vox Sang; 2014 Jul; 107(1):97-9. PubMed ID: 24517203
[TBL] [Abstract][Full Text] [Related]
16. An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1.
Jeimy SB; Krakow EF; Fuller N; Tasneem S; Hayward CP
J Thromb Haemost; 2008 Feb; 6(2):395-7. PubMed ID: 18047547
[No Abstract] [Full Text] [Related]
17. Acquired factor V deficiency in a patient without evidence of a classical inhibitor.
Sosa IR; Ellery P; Mast A; Neff AT; Gailani D
Haemophilia; 2014 Jan; 20(1):e81-3. PubMed ID: 24118596
[No Abstract] [Full Text] [Related]
18. Successful management of transcatheter aortic valve implantation by platelet transfusions in a nonagenarian patient with severe autoimmune factor V deficiency.
Mouton C; Leroux L; Bonnet G; Seguy B; Lafargue A; Baulier G; Castet S; Fiore M
Ann Hematol; 2019 Aug; 98(8):1991-1992. PubMed ID: 30830247
[No Abstract] [Full Text] [Related]
19. Bovine thrombin induces an acquired coagulopathy in sensitized patients undergoing revision spinal surgery: a report of two cases.
Poynton AR; Nelson MC; McCance SE; Levine RL; O'Leary PF
Spine (Phila Pa 1976); 2003 Jun; 28(12):E221-3. PubMed ID: 12811284
[TBL] [Abstract][Full Text] [Related]
20. Factor V inhibitor in neonatal intracranial hemorrhage secondary to severe congenital factor V deficiency.
Lee WS; Chong LA; Begum S; Abdullah WA; Koh MT; Lim EJ
J Pediatr Hematol Oncol; 2001 May; 23(4):244-6. PubMed ID: 11846304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]